Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Cloudnine to Invest Rs...

    Cloudnine to Invest Rs 400 Crore for expansion

    Written by savita thakur thakur Published On 2017-03-13T11:16:53+05:30  |  Updated On 13 March 2017 11:16 AM IST
    Cloudnine to Invest Rs 400 Crore for expansion
    CHENNAI: With the view of increasing demand of maternal care for women in India, Cloudnine, a Bengaluru-based maternity care hospital chain has announced that it is going to enter into preventive health management for women.


    Hindu also reports that the company plans to invest Rs. 400 crore in coming year. Cloudnine plans to develop seven hospitals in Bengaluru, Delhi, Mumbai and Chandigarh by June 2018.The investment will be done in genetic profiling and other technology for women wellness.


    An additional Rs. 150 crore will be spent on strengthening the Chennai market and expanding to newer markets such as Kochi, Visakhapatnam and Coimbatore.


    Earlier, the company invested in Transmural Biotech, a Spanish company, for early screening of breast cancer.


    Speaking with BuisnessLine over the increasing demand of mother and neo-natal care centres, Nitin Nag, Regional Director, Cloudnine Group of Hospitals said, India has lack of maternal healthcare centre and lack of services for mother and their newborn babies.


    He further said that around four in every 200 deliveries result in complications. But many hospitals in India lack a dedicated facility such as neonatal intensive care unit to handle complications and physicians specialised in neonatal care . “So, we collaborate with other hospitals and share the facility on need basis."


    “There are times when we have more babies from other hospitals in the unit than in-house babies," Nag added.


    Talking more about their expansion and reason behind the high investment Nag told media that “Around 15 per cent of Indian population suffer from fertility issues. Earlier, people who seek fertility treatment were in the age group 27 to 35. Now, we are seeing people between 23 and 31 years coming for fertility treatment.”


    Cloudnine Hospitals is a leading chain of maternity and childcare hospitals which currently operates in the cities Bengaluru, Chennai, Gurgaon, Mumbai and Pune, and has more than 30,000 deliveries to its credit.


    CloudnineInvestmentpreventive health management for womenRs 400 croreWomen Healthcare Management
    Source : with inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok